¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ternary complex model"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • model
    ¸ðÇü, ¸ðµ¨
  • model population
    ¸ðÇüÀα¸
  • model psychosis
    ¸ðÇüÁ¤½Åº´
  • multiple logistic model
    ´ÙÁß·ÎÁö½ºÆ½¸ðÇü
  • multiplicative model
    °ö¼À¸ðÇü
  • multistage model
    ´Ù´Ü°è¸ðÇü
  • multitarget model
    ´ÙÇ¥Àû¸ðµ¨
  • multitarget multihit model
    ´ÙÇ¥Àû´ÙÀûÁ߸ðµ¨
  • multitarget single hit model
    ´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
  • organic model
    À¯±â¸ðÇü
  • plaster model
    ¼®°í¸ðÇü
  • proportional hazards model
    ºñ·ÊÀ§Çè¸ðÇü
  • psychodynamic experiential model
    Á¤½Å¿ªµ¿°æÇè¸ðÇü
  • reserve model
    ¿¹ºñ¸ðÇü
  • role model
    ¿ªÇÒÇ¥º»Çü, ¿ªÇÒ¸ðµ¨
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • linear quadratic model
    ¼±Çü¹æÇü¸ðµ¨, ¼±ÇüÀÌÂ÷ÇÔ¼ö¸ðµ¨
  • model
    ¸ðÇü, ¸ðµ¨
  • model population
    ¸ðÇüÀα¸
  • model psychosis
    ¸ðÇüÁ¤½Åº´
  • multiple logistic model
    ´ÙÁß·ÎÁö½ºÆ½¸ðÇü
  • multistage model
    ´Ù´Ü°è¸ðÇü
  • multitarget model
    ´ÙÇ¥Àû¸ðµ¨
  • multitarget multihit model
    ´ÙÇ¥Àû´ÙÀûÁ߸ðµ¨
  • multitarget single hit model
    ´ÙÇ¥Àû´ÜÀÏÀûÁ߸ðµ¨
  • mutiplicative model
    °ö¼À¸ðÇü
  • organic model
    À¯±â¸ðÇü
  • plaster model
    ¼®°í¸ðÇü
  • proportional hazards model
    ºñ·ÊÀ§Çè¸ðÇü
  • psychodynamic experiential model
    Á¤½Å¿ªµ¿°æÇè¸ðÇü
  • reserve model
    ¿¹ºñ¸ðÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Golgi s complex
    °ñÁöÀåÄ¡, °ñÁöº¹ÇÕü.
  • HLA complex
    HLAÀ¯ÀüÀÚ±Õ.
  • HLA complex
    HLAÀ¯ÀüÀÚ±Õ.
  • Immune complex
    ¸é¿ªº¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • Lutembacher s complex
    ·òÅÁ¹Ù½¬¿¡ÁõÈıº.
  • MHC => major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • Oedipism=Oedipus complex
    ¿¡µðǪ½º ÄÞÇ÷º½º
  • Oedipus complex
    ¿¡µðǪ½º ÄÞÇ÷º½º.
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦È°¼ºÁ¦º¹ÇÕü
  • amylase complex with immunoglobulin = macroamylase
    ¸é¿ª±ÛºÒ¸°¾Æ¹Ð¶óÁ¦º¹ÇÕü=¸¶Å©·Î¾Æ¹Ð¶óÁ¦
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • antigen-antibody complex
    Ç׿ø-Ç×üº¹ÇÕü
  • antigen-antibody complex, soluble
    ¼ö¿ë¼º Ç׿ø-Ç×üº¹ÇÕü
  • ghon complex
    °ï º¹ÇÕü, Ghon º¹ÇÕü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • health belief model
    °Ç°­¹ÏÀ½ ¸ðÇü.
  • homeostatic model
    Ç×»ó¼º ¸ðÇü(Ù¼úþ)<Ç¥ÁØÇü>
  • in-the-ear model
    ±Í¼ÓÇü(º¸Ã»±â)
  • linear quadratic model
    ¼±Çü¹æÇü¸ðµ¨, ¼±ÇüÀÌÂ÷ÇÔ¼ö¸ðµ¨, LQ¸ðµ¨
  • model population
    ¸ðÇüÀα¸(ËÎÌ´ËöË´).
  • model psychosis
  • model trimmer
    ¸ðÇüÃÊÇÕ±â(¡­ÞûùêѦ).
  • multitarget model
    ´ÙÇ¥Àû¸ðµ¨
  • multitarget multihit model
    ´ÙÇ¥Àû´ÙÀûÁß
  • multitarget single hit model
    ´ÙÇ¥Àû´ÜÀÏÀûÁß
  • nuclear model
    (¿øÀÚ)ÇÙ¸ðÇü(ê«í­ú·Ù¼úþ).
  • organic model
    À¯±â¸ðÇü(¡­Ù¼úþ).
  • plaster model
    ±é½º Çü(¡­úþ), ¼®°í ¸ðÇü.
  • psychodynamic experiential model
    Á¤½Å¿ªµ¿Àû °æÇè¸ðµ¨
  • reserve model
    ¿¹ºñ¸ðÇü(çãÝáÙ¼úþ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Campbell model
    Ä·º§ ¸ðµ¨
  • central complex
    Á᫐ º¹ÇÕü(ñéãýÜÜùêô÷)
  • CF0-CF1 complex
    CF0-CF1 º¹ÇÕü(ÜÜùêô÷)
  • charge transfer complex
    ÀüÇÏÀ̵¿ º¹ÇÕü(ï³ùÃì¹ÔÑÜÜùêô÷)
  • closed-promoter complex
    ´ÝÈùÇÁ·Î¸ðÅÍ º¹ÇÕ¹°(ÜÜùêÚª)
  • cloverleaf model
    Ŭ·Î¹öÀÙ ¸ðµ¨
  • coenzyme Q-cytochrome c reductase complex
    º¸È¿¼Ò(ÜÍý£áÈ) Q¡¤»çÀÌÅäÅ©·Ò C ¸®´ÚÅ×À̽º (ÔÒ) complex III
  • complex
    º¹ÇÕ¹°(ÜÜùêÚª)
  • complex glycoproteins
    º¹ÇÕ ´ç´Ü¹éÁú(ÜÜùêÓØÓ±ÛÜòõ)
  • complex hapten
    º¹ÇÕ(ÜÜùê) ÇÕÅÙ
  • complex ion
    º¹ÇÕ(ÜÜùê) ÀÌ¿Â
  • complex lipid
    º¹ÇÕÁöÁú(ÜÜùêò·òõ)
  • complex locus
    º¹ÇÕºÎÀ§(ÜÜùêÝ»êÈ)
  • complex medium
    º¹ÇÕ ¹è¾ç¾×(ÜÜùêÛÆå×äû)
  • complex oligosaccharides
    º¹ÇÕ(ÜÜùê) ¿Ã¸®°í»çÄ«¶óÀ̵å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ARC accelerating rate calorimetry; acquired immunodeficiency syndrome-related complex; active renin conc...
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
QRS in electrocardiography, the complex consisting of Q, R, and S waves, corresponding to depolarization...
SFC soluble fibrin complex; soluble fibrin-fibrinogen complex; spinal fluid count
CPK cell population kinetic [model]; creatine phosphokinase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FFM Five Factor Model
FLMP Fuzzy Logical Model of Perception
GLM General Linear Model
GLM Generalised Linear Model
HBM Health Belief Model
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nuclear model
    ÇÙ ¸ðÇü
  • plaster matrix

    plaster model

    ¼®°í ¸ðÇü, ±é½ºÇü
  • psychodynamic experiential model
    Á¤½Å ¿ªµ¿Àû °æÇè ¸ðµ¨
  • symmetry model
    ´ëĪÇü, ´ëμ³
  • wave model
    ÆÄÇü
  • working model for bridgework
    °¡°ø ÀÇÄ¡ ÀÛ¾÷ ¸ðÇü
  • acyl-plasminogen streptokinase activator complex
    ¾Æ½Ç-Çø®Áî¹Ì³ë°Õ½ºÆ®·¾ÅäŰ³ªÁ¦ Ȱ¼º
  • AIDS related complex
    AIDS °ü·Ã º¹ÇÕÁõ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ°ú ¿¬°üµÈ Áúȯ, ÈÄõ¼º ¸é¿ª °áÇÌÁõ-°ü·Ã º¹ÇÕü, ÈÄõ¼º ¸é¿ª °áÇÌÁõ °ü·Ã º¹ÇÕ ¹ÝÀÀ
  • amylase complex with immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸° ¾Æ¹Ð¶óÁ¦ º¹ÇÕü
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ ÀÀ°í °áÇÕü
  • antibody-drug-cell complex
    Ç×ü ¾à¹° ¼¼Æ÷ º¹ÇÕü
  • antigen antibody complex
    Ç׿ø Ç×ü º¹ÇÕü
    Ç׿ø°ú Ç×ü°¡ °áÇÕÇÑ °Í. ¸é¿ª º¹ÇÕü¶ó°íµµ ÇÑ´Ù. Ç×ü´Â Ç׿ø°ú °áÇÕÇÏ¿© º¹ÇÕü¸¦ ¸¸µé¸é º¸Ã¼ Ȱ¼ºÈ­ ÀÛ¿ëÀ» °¡Áö°Ô µÈ´Ù. ±×·¡¼­ »ýü ³»¿¡¼­ ¸é¿ª º¹ÇÕü°¡ Çü¼ºµÇ¸é ±× ÁÖº¯¿¡¼­ ºÎü°¡ Ȱ¼ºÈ­µÇ¾î ¿°Áõ¹ÝÀÀÀ» ¹ß»ý½ÃŰ´Â ¼ÀÀÌ´Ù. Ç׿ø Ç×ü º¹ÇÕü´Â ħ°­¼ºÀÇ °ÍÀ¸·Î µÇ±â ½±´Ù. µû¶ó¼­ Ç׿øÀÇ Ä§ÀÔ ºÎÀ§¿¡ ¿°Áõ¹ÝÀÀÀÌ »ý±â±â ½±´Ù.
  • avian leukosis complex virus
    Á¶·ù ¹éÇ÷±¸Áõ ¹ÙÀÌ·¯½º
  • central renal echo complex
    ½Å Á᫐ ¿¡ÄÚ º¹ÇÕü
  • complex
    º¹Àâ, º¹ÇÕÀÇ
    com
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
model 1. A representation of something, often idealised or modified to make it conceptually easier to understand.
2. Something to be imitated.
3. In dentistry, a cast.
Origin: It. Midello, fr. L. Modus, measure, standard
(05 Mar 2000)
Monod-Wyman-Changeux model A model used to explain the allosteric form of cooperativity; in this model, an oligomeric protein can exist in two conformational states in the absence of the ligand; these states are in equilibrium and the one that is predominant has a lower affinity for the ligand (which binds to the protein in a rapid equilibrium fashion).
Synonym: concerted model.
(05 Mar 2000)
wax model denture A setup of artificial teeth so fabricated that it may be placed in the patient's mouth to verify esthetics, for the making of records, or for any other operation deemed necessary before final completion of the denture.
Synonym: wax model denture.
(05 Mar 2000)
collisionless plasma model <radiobiology> Model of a plasma in which the density is so low, or the temperature so high, that close binary (two-body) collisions have practically no significance (on certain timescales) because the time scales of interest are shorter than the collision time. Yields valid physical results for timescales much shorter than the average collision time in a real plasma.
(09 Oct 1997)
compartmental model <epidemiology> A mathematical model which divides hosts into different compartments according to their infectious state. A typical model for microparasites might be an SEIR model. Sometimes referred to as a prevalence model.
(05 Dec 1998)
computer model A mathematical representation of the functioning of a system, presented in the form of a computer program.
Synonym: computer simulation.
(05 Mar 2000)
concerted model A model used to explain the allosteric form of cooperativity; in this model, an oligomeric protein can exist in two conformational states in the absence of the ligand; these states are in equilibrium and the one that is predominant has a lower affinity for the ligand (which binds to the protein in a rapid equilibrium fashion).
Synonym: concerted model.
(05 Mar 2000)
multiplicative model A model in which the joint effect of two or more causes is the product of their effects if they were acting alone.
(05 Mar 2000)
multistage model A mathematical model, mainly for carcinogenesis, based on the theory that a specific carcinogen may affect one among a number of stages in the development of cancer.
(05 Mar 2000)
continuous time model <epidemiology> A model in which the system changes continuously over time. Derivatives (e.g. DY/dt ) are the mathematical formalism for describing such continuous change. The differential equation which embodies a model provides the values of these derivatives at any particular time point; calculus or a computer can then be used to move the state of the model forwards in time.
Continuous models have the advantage over discrete time models in that they are more amenable to algebraic manipulation, although they are slightly harder to implement on a computer.
The same as a differential equation model.
(05 Dec 1998)
cooperativity model A model used to explain the property of cooperativity observed in certain enzymes; e.g., allosterism or hysteresis.
(05 Mar 2000)
seir model <epidemiology> A class of compartmental prevalence models, with compartments Susceptible, Latent (Exposed), Infectious and Recovered. Takes its name from a common notation. In the notation used in the course, this would be an XHYZ model. Many permutations possible.
(05 Dec 1998)
sliding filament model <cell biology> Generally accepted model for the way in which contraction occurs in the sarcomere of striated muscle, by the sliding of the thick filaments relative to the thin filaments.
(18 Nov 1997)
spawner-recruit model Biological model that relates the number of recruits or mature spawners in one generation to the number of spawners in the previous generation.
(09 Oct 1997)
statistical model A formal representation for a class of processes that allows a means of analyzing results from experimental studies, such as the Poisson model or the general linear model; it need not propose a process literally interpretable in the context of the individual case.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Electra complex
    ¿¤·ºÆ®¶ó ÄÞÇ÷º½º
  • Golgi complex
    °ñÁö º¹ÇÕü
  • Oedipus complex
    Ä£¸ðº¹ÇÕ(¾ÆµéÀÌ ¾Æ¹öÁö¿¡ ¹Ý¹ßÇÏ°í ¾î¸Ó´Ï¸¦ »ç¸ðÇÏ´Â °æÇâ
  • cinema complex
    ½Ã³×¸¶ ÄÞÇ÷º½º(º¹¼öÀÇ È¦À» °¡Áø ¿µÈ­°ü) 
  • complex
    º¹ÀâÇÑ;ÂøÀâÇÑ;(¹®Á¦°¡)¾î·Á¿î;º¹ÇÕÀÇ;ÇÕ¼ºÀÇ;(¹®ÀåÀÌ)º¹ÇÕÀÇ;º¹¹®ÀÇ;ÇÕ¼º¹°;º¹ÇÕü;(°Ç¹° µîÀÇ)ÁýÇÕü;°øÀå´ÜÁö;ÄÞÇ÷º½º;º¹ÇÕ;(¾î¶² °Í¿¡ ´ëÇÑ)°íÁ¤ °ü³ä;°úµµÀÇ Çø¿À(°øÆ÷)
  • complex fraction
    º¹ºÐ¼ö
  • complex number
    º¹¼Ò¼ö
  • complex plane
    °¡¿ì½º Æò¸é;º¹¼Ò(¼ö)Æò¸é
  • complex sentence
    º¹¹®(Á¾¼ÓÀýÀ» °¡Áø ¹®)
  • compound-complex sentence
    Áߺ¹¹®(Á¾¼ÓÀýÀ» ÇϳªÀÌ»ó °¡Áø Áß¹®)
  • culture complex
    ¹®È­ º¹ÇÕü
  • edifice complex
    °Å´ë °ÇÃà ÁöÇâ(ÇàÁ¤°èȹÀ̳ª °ÇÃà°¡ÀÇ ±¸»ó µîÀÌ)
  • educationalindustrial complex
    ½ÅÇÐ ¿îµ¿
  • immune complex
    ¸é¿ª º¹ÇÕü
  • inferiority complex
    ¿­µî ÄÞÇ÷º½º;¿­µî°¨;¿­µîÀǽÄ;ÁÖ´ª;¿Ö°îµÈ ¸¶À½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á